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Perinatal transmission of dengue virus in Puerto Rico: a case 
report
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Abstract
We report a laboratory confirmed case of vertical transmission of dengue in a mother-child pair in 
the eastern part of Puerto Rico. The clinical course of the pregnant female suggested a GBS 
infection, but laboratory tests confirmed it was dengue infection, one week after delivery. The 
male infant was healthy at birth, but one week after birth developed clinical complications related 
to vertical transmission of dengue. This report targets physicians in dengue endemic countries like 
Puerto Rico to be aware of the possibility of vertical transmission of dengue in symptomatic 
pregnant patients, especially around the time of delivery.
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1. INTRODUCTION
Dengue is caused by four related dengue viruses (DENV) −1, −2, −3, and −4, and infection 
with one DENV is thought to provide lifelong immunity to that virus-type and partial short 
term protection to other DENVs. Most DENV infections are asymptomatic especially first 
infections. The clinical spectrum of disease ranges from a mild, non-specific acute febrile 
illness, to classic dengue fever (DF) to severe, life-threatening disease including dengue 
hemorrhagic fever (DHF) and dengue shock syndrome (DSS) [1]. Second and subsequent 
DENV (secondary) infections have been associated with more severe disease.[2]
DENV transmission is primarily between humans through infected Aedes mosquitoes. The 
incubation period in the human host is typically one week (range 3 to 14 days) with viremia 
occurring 1 to 2 days before symptom onset and lasting approximately one week. During 
this period of viremia, DENV can also be transmitted as a bloodborne infection which has 
been observed from receipt of donor organs or tissue, blood transfusion [3–6], after 
occupational accidents in healthcare settings, and perinatal transmission [7,8].
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Historically, dengue was thought to be primarily a childhood disease; however, an increasing 
proportion of cases are now being reported among adults [2,9,10]. In Puerto Rico, half of all 
reported dengue cases are adults ≥20 years of age while adolescents 15 to 19 years old have 
the highest incidence of laboratory-confirmed den- gue; a group whose infants make up 
nearly one-fifth of the birth cohort [11]. Because of this, women of childbearing age are now 
increasingly at risk of acquiring DENV infection while pregnant and may be more likely to 
develop severe disease as second infections occur later in life. Here we describe a unique 
case of perinatal DENV transmission involving a teenage mother and her infant.
2. CASE SUMMARY
2.1. Mother
A 17 year old woman, Grava: 1 Para: 1 Abortions: 0 Stillbirth: 0, who regularly attended 
prenatal care clinic since 17 weeks gestation, presented to the Emergency Department (ED) 
on 16 June 2010. She was 38 4/7 weeks gestation with a chief complaint of fever for one 
day, headache, and nausea. The patient had recently moved to Puerto Rico from 
Pennsylvania. She had one previous hospitalization for appendectomy at age 7 and no 
chronic medical conditions. The patient denied tobacco, alcohol or illicit drug use, and she 
was HIV, HBV and RPR non-reactive and Group B Streptococcus (GBS) positive at 34 
weeks gestation. At initial presentation, she had a temperature of 38.3°C, a heart rate of 140 
bpm, respiratory rate of 18 bpm, and blood pressure of 109/46 mm Hg. She was alert, active 
and in moderate distress with complaints of pelvic pain. On physical examination, her cervix 
was two centimeters dilated and she was thought to be in early labor. Laboratory studies 
included a complete blood count (CBC) with leukocyte count of 9500 mm3 and a normal 
differential, hematocrit of 31.7%, and a platelet count of 105,000 mm3. She was mildly 
hyponatremic with serum sodium of 134.0 meq/L. Blood and urine cultures were taken and 
the patient was admitted for intravenous hydration and empiric treatment with ampicillin and 
gentamicin for GBS. After intravenous hydration, the decision was made to transfer the 
patient to the delivery room were an amniotomy was performed to promote active labor. 
After 512  hours of active labor, the patient delivered a male infant at 16:13 on 17 June 2010 
by spontaneous vaginal delivery. She did not have any abnormal bleeding during labor or 
delivery, and did not require any blood products.
The patient continued to have fever and headache for 5 more days, and admission blood and 
urine cultures, and placental cultures were all negative. Her platelet count declined further to 
a low of 59,000 mm3 on the day of fever defervescence. That day a serum sample was sent 
to the Centers for Disease Control and Prevention (CDC) Dengue Branch Laboratory in San 
Juan, Puerto Rico for dengue diagnostic testing. The patient did not develop any evidence of 
plasma leakage as indicated by hemoconcentration, ascites, pleural effusions, or 
hypoalbuminemia. She did not develop any hemorrhagic manifestations other than moderate 
post partum vaginal bleeding that lasted about two weeks. The patient did not have any other 
signs or symptoms associated with dengue. However, her aspartate aminotransferase (AST) 
and alanine aminotranferase (ALT) were slightly elevated at 95 and 46 IU/L, respectively on 
22 June 2010, while her total bilirubin (0.6 mg/dl) remained normal during the hospital stay. 
The patient was discharged home on 23 June 2010 with a platelet count of 118,000 mm3, an 
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AST of 53 IU/L, ALT of 31 IU/L, and a hematocrit of 32.5%. When evaluated 2 weeks later, 
she had fully recovered without any complications.
2.2. Infant
The infant weighted 2,892 grams, and had a length of 20 inches and a head circumference of 
13 inches. APGAR scores were 8 and 9 at one and five minutes after birth, respectively. The 
infant was transferred immediately to the Neonatal Intensive Care Unit (NICU) to be 
evaluated for GBS sepsis. Upon admission, the infant had a temperature of 36.5°C, a heart 
rate of 141 bpm, a respiratory rate of 35 bpm, and a blood pressure of 60/43 mm Hg. Blood 
and urine cultures were taken and the infant was given ampicillin and gentamycin 
empirically. Physical examination was unremarkable. Laboratory studies showed a leukocyte 
count of 11,000 mm3 and a normal differential, a platelet count of 260,000 mm3, and a 
hematocrit of 43.5%. Blood and urine cultures taken at birth were negative.
The infant remained stable with no changes observed in his physical examination, vital signs 
or behavior until the evening of June 23, when he became hypoactive and unable to suck and 
feed. On physical examination, the infant had a temperature of 36.5°C and a heart rate of 
130 bpm, respiratory rate of 46 bpm and BP 64/39 mm Hg. He was pale and had a fine 
reticular rash. The remainder of his examination was unremarkable. The patient had no 
lymphadenopathy, petechiae, ecchymosis, purpura, or hepatomegaly. Laboratory studies 
showed a leukocyte count of 4900 mm3, a platelet count of 116,000 mm3 and a hematocrit 
of 36.6%; he was hyponatremic with a sodium of 130 meq/L. Blood and urine cultures were 
taken, and the possibility of a fungal infection was entertained as there had been recent cases 
in the hospital. Antibiotics were changed to vancomycin and imipenem, and amphotericin 
was added.
The next day on 24 June, the infant remained hypoactive, pale, and unable to suck. He had a 
leukocyte count of 4600 mm3, a platelet count of 84,000 mm3, and a hematocrit of 35.6%. 
No bleeding was observed, and there was no change in his physical examination or vital 
signs. At this point, the mother’s serum was reported as positive for DENV-1 by reverse 
transcriptase-polymerase chain reaction (RT-PCR). The possibility of vertical transmission 
was entertained, and a serum sample was sent to CDC for diagnostic testing. The infant’s 
platelet count decreased to a low of 36,000 mm3 on June 26, and he was given a platelet 
transfusion. No bleeding was observed, a head ultrasound was normal, and stool and urine 
analyses were negative for red blood cells. On June 27, laboratory studies showed a 
prothrombin time (PT) of 11.4 seconds; partial thromboplastin time (PTT) of 63.3 seconds, 
and international normalized ratio (INR) of 1.05, and the infant was given fresh frozen 
plasma and evaluated for disseminated intravascular coagulation (DIC). His coagulation 
profile normalized on June 28. An abdominal ultrasound found prehepatic and perisplenic 
free fluid, suggesting ascites.
Dengue diagnostic results were received on June 29, which were positive for DENV-1 by 
RT-PCR. The next day, the infant was more active and his sucking improved. A CBC 
showed a leukocyte count of 7100 mm3, a platelet count of 98,000 mm3, and a hematocrit of 
28.7%. He was given a packed red blood cell transfusion for symptomatic anemia with 
hypoxia (O2 saturation 93%). On July 7, his platelet count reached normal values for age 
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(168,000 mm3). The patient had no other complications and he was discharged home on 18 
July 2010.
3. DISCUSSION
This case illustrates the importance of considering dengue as a cause of acute febrile illness 
in pregnant women residing in, or traveling to endemic countries, and suggests that perinatal 
DENV transmission is likely to be under-recognized. Unlike other cases reported in the 
literature [12–31] the infant we described never developed fever. Newborn infants often do 
not mount a febrile response to an infection, and consequently cases of perinatal DENV 
transmission may be missed if the mother is not identified as having dengue. This infant had 
non-specific findings consistent with congenital dengue including hyponatremia, leucopenia, 
and thrombocytopenia, an elevated PTT, and ascites. However, he was diagnosed as having 
dengue because DENV-1 was detected by RT-PCR in his mother’s serum. Perinatal 
transmission of DENV was supported by the fact that the mother was acutely febrile at the 
time of delivery, the infant never left the hospital after an uneventful delivery and was 
unlikely to have had mosquito-borne DENV transmission and all cultures were negative for 
GBS.
Perinatal dengue, as this case illustrates, may result in severe dengue and prolonged hospital 
stays [22]. Of the 33 cases of perinatal DENV transmission reported with clinical data, all 
developed fever and thrombocytopenia in the first two weeks after birth, and 39% had a 
hemorrhagic manifestations, 24% developed hypotension, and 33% had hepatomegaly.
Our case and all of the perinatal transmission cases described in the literature involved a 
woman who was acutely ill with dengue at or near the time of delivery. It has been 
hypothesized that when this happens, there is an insufficient level of protective maternal 
anti-DENV IgG to transfer to the fetus as the women is at or near the peak of DENV 
viremia. In dengue endemic areas, women with intrapartum or post partum fever and a 
negative evaluation for bacterial or other causes should be tested for dengue and informed of 
the risk of perinatal dengue. Special attention should be paid to their infants who if infected, 
might become ill in the first two weeks of life. As with other diseases, this may mean that 
the infant presents with a change in their level of activity, responsiveness, muscle tone, or 
ability to suck and swallow, and they may not develop classic signs of dengue such as fever 
and rash.
For nearly four decades, the Puerto Rico Department of Health and CDC have monitored 
dengue incidence in Puerto Rico via a passive surveillance system. Even though dengue has 
been endemic since the late 1960s and it is a reportable condition by law, cases are thought 
to be under-recognized and under-reported. Pregnancy-associated dengue cases may not 
always be reported as such. Pregnant women with dengue may be diagnosed with other 
febrile illnesses or HELLP syndrome, especially if they present with elevated liver enzymes 
and a low platelet count. Since there is no rapid diagnostic test for dengue, physicians need 
to have a high index of suspicion and test for dengue while ruling out these other etiologies.
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Future studies should aim to determine the incidence of perinatal DENV transmission, risk 
factors for dengue in the neonate, and poor outcomes among infants born to women with 
dengue during pregnancy. Increased awareness of the possibility of maternal dengue and 
perinatal transmission is important to prevent complications in both the mother and the 
newborn.
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